---
title: "Wellnex Life (ASX:WNX) : Appendix 4C and Quarterly Report for June 2024 Quarter"
description: "Wellnex Life (ASX: WNX), owner and developer of some of Australia's leading health brands, has recently published a key ASX announcement. "
---

[The Latest ](https://www.barclaypearce.com/blog)

# [Wellnex Life (ASX:WNX) : Appendix 4C and Quarterly Report for June 2024 Quarter](https://www.barclaypearce.com/blog/wellnex-life-asxwnx-appendix-4c-and-quarterly-report-for-june-2024-quarter)

 Written by [Barclay Pearce Capital](https://www.barclaypearce.com/blog/author/barclay-pearce-capital) | Jul 31, 2024 6:36:37 AM

We are pleased to share [Wellnex Life](https://www.linkedin.com/company/wellnex-life/) (ASX:WNX), owner and developer of some of Australia's leading health brands, has recently published a key ASX announcement. 

 

### Announcement Highlights

- Record Cash inflows from brand sales
- Operating profit of $0.5 million (Q4 FY24)
- Quarterly Cash Receipts (Q4 FY24) $4.9 million
- 56% rise from previous quarter (Q3 FY24: $3.12 million)
- 122% rise in margins for 6 months ending June 30 compared to previous 6 months
- Investment of $1.35 million in the quarter for the purchase 12 month's supply of ingredients and packaging for Pain Away and for the launch of new Wakey Wakey product lines
- Extension of new 2 innovative lines of Wakey Wakey which have commenced ranging in major pharmacy and grocery retailers in July
- Launch of medicinal cannabis brand commenced sales in July for the SAS-B market
- Wellnex Life progresses with dual listing on the [London Stock Exchange](https://www.linkedin.com/company/london-stock-exchange/)
- Placement completed with participation from UK based investors post close of quarter

 

Wellnex Life (ASX: WNX) is pleased to provide the following operational update along with its Appendix 4C for the quarter ended June 2024. ("Q4 FY24").

The company recorded Cash Receipts for Q4 FY24 of $4.9 million, an increase of 56% on the previous quarter (Q3 FY24: $3.12 million), with 82% of all cash receipts coming from brand sales resulting in an operating profit of $0.5 million for the quarter.

The increasing sales of Wellnex Life's brands has resulted in margins increasing 120% in the last half of FY24 compared to the first half of FY24 to 40% (H1FY24: 18%).

 

Read the full Wellnex Life announcement [here](https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02834034-3A647030%26v=70bc033a22188bdfefb8a0b8ad3c24897ef2837d).

*To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.*  

[View full post](https://www.barclaypearce.com/blog/wellnex-life-asxwnx-appendix-4c-and-quarterly-report-for-june-2024-quarter)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Barclay Pearce Capital"
  },
  "dateModified" : "2024-07-31T06:36:37.697Z",
  "datePublished" : "2024-07-31T06:36:37Z",
  "headline" : "Wellnex Life (ASX:WNX) : Appendix 4C and Quarterly Report for June 2024 Quarter",
  "image" : {
    "@type" : "ImageObject",
    "height" : 350,
    "url" : "https://www.barclaypearce.com.au/hubfs/wellnex-life-barclay-pearce-capital-successful-raise-acquisition-painaway.jpg",
    "width" : 600
  },
  "mainEntityOfPage" : "https://www.barclaypearce.com/blog/wellnex-life-asxwnx-appendix-4c-and-quarterly-report-for-june-2024-quarter",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "The Latest"
  }
}
```